3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Colorectal Neoplasms
5
Ovarian Neoplasms
2
Fallopian Tube Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Hepatocellular
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Sarcoma, Kaposi
1
Rectal Neoplasms
1
Oesophagogastric Cancer
1
Non-small Cell Lung Cancer Metastatic
1
Metastatic Colorectal Cancer With Left-sided Primary Tumor
1
Meningeal Carcinomatosis
1
HER-2 Negative Breast Cancer
1
EGFR Positive Non-small Cell Lung Cancer
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Colorectal Cancer Liver Metastasis
1
Advanced Primary Liver Cancer
1
Adenocarcinoma of Lung
1
Interventions
toripalimab
1
Pemetrexed
1
Paclitaxel
1
Erlotinib Hydrochloride
1
Docetaxel
1
Cisplatin
1
Carboplatin
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
EGFR Positive Non-small Cell Lung Cancer
×
Bevacizumab
×
Clear all
NCT03126799
2022-04-06
AvaTa
National Cancer Center, Korea
Phase 2
Unknown
128 enrolled